Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer

Sarah L. Kerns, Ashley Amidon Morlang, Sharon M. Lee, Derick R. Peterson, Brian Marples, Hong Zhang, Kevin Bylund, Doug Rosenzweig, William A. Hall, Kim De Ruyck, Barry S. Rosenstein, Richard G. Stock, Antonio Gómez‐Caamaño, Ana Vega, Paloma Sosa‐Fajardo, Begoña Taboada‐Valladares, Miguel E. Aguado‐Barrera, Chris Parker, Liv Veldeman, Valérie Fonteyne, Renée Bultijnck, Chris J. Talbot, R.P. Symonds, Kerstie Johnson, Tim Rattay, Adam Webb, Maarten Lambrecht, Dirk De Ruysscher, Ben Vanneste, Ananya Choudhury, Rebecca Elliott, Elena Sperk, Carsten Herskind, Marlon R. Veldwijk, T. Rancati, B. Avuzzi, R. Valdagni, D. Azria, Marie-Pierre Farcy Jacquet, Jenny Chang‐Claude, Petra Seibold, Catharine West, Michelle C. Janelsins, Yuhchyau Chen, Edward M. Messing, Gary R. Morrow, D. Azria, Erik Briers, Jenny Chang‐Claude, Ananya Choudhury, Alison M. Dunning, Rebecca Elliott, Sara Gutiérrez‐Enríquez, T. Rancati, Tim Rattay, Barry S. Rosenstein, Dirk De Ruysscher, Petra Seibold, Elena Sperk, R.P. Symonds, Hilary Stobart, Chris J. Talbot, Ana Vega, Liv Veldeman, Tim Ward, Adam Webb, Catharine West